| UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) QL-ACC | SALUD | · | · | · | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-A1-ACC | SALUD | 1,71% | -8,44% | -45,23% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-A2-ACC | SALUD | 1,74% | -8,10% | -44,80% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-B-ACC | SALUD | 2,56% | -5,88% | -42,58% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY (JPY) I-A1-ACC | SALUD | -3,78% | -12,47% | -48,09% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACC | SALUD | 1,50% | -8,76% | -45,45% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY N-ACC | SALUD | -0,08% | -12,65% | -49,22% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY P-ACC | SALUD | 0,79% | -10,65% | -47,33% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY Q-ACC | SALUD | 1,67% | -8,54% | -45,33% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY QL-ACC | SALUD | · | · | · | · |
| UBS (LUX) DIGITAL HEALTH EQUITY SEEDING P-ACC | SALUD | 2,01% | -7,38% | -44,07% | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) QL-DIST | RFI EMERGENTES | 12,22% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) QL-ACC | RFI EMERGENTES | 14,95% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-ACC | RFI EMERGENTES | 13,71% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-DIST | RFI EMERGENTES | 8,08% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-A1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-B-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) K-1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) P-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-A1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-B-DIST | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) K-1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) P-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) Q-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | RFI EMERGENTES | · | · | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | BIOTECNOLOGÍA | 41,22% | 28,46% | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | BIOTECNOLOGÍA | 41,30% | 28,19% | 26,02% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 10,40% | 4,70% | -42,64% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 11,67% | 8,00% | -39,72% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | 10,80% | 8,36% | -29,97% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | RVI CHINA | 9,49% | 4,57% | -33,99% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) Q-ACC | RVI CHINA | 10,75% | 7,88% | -30,62% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A3-ACC | RVI CHINA | 11,50% | 8,99% | -29,17% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (CHF PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 28,76% | 54,58% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR HEDGED) P-ACC | RVI GLOBAL | 26,75% | 47,63% | 30,65% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) P-ACC | RVI GLOBAL | 25,96% | · | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 28,92% | 54,52% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) Q-ACC | RVI GLOBAL | 27,02% | 51,58% | 56,68% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (GBP PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 28,92% | 63,51% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (USD PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 27,71% | 52,89% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) P-ACC | SALUD | 11,85% | 16,05% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) Q-ACC | SALUD | 12,74% | 18,84% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (EUR HEDGED) P-ACC | SALUD | 12,17% | 16,33% | · | · |
